Xspray Pharma AB (publ) (XSPRAY): key financial figures for fiscal year 2025 (in SEK), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025): kr 0
Net Income/Loss (FY2025): -kr 171.4M
Total Assets (FY2025): kr 769.3M
Total Equity (FY2025): kr 604.6M
Cash Flows from Operating Activities (FY2025): -kr 193.2M

Source: Xspray Pharma AB (publ) annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Xspray Pharma AB (publ) (XSPRAY): key financial figures for fiscal year 2025 (in SEK), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025): kr 0
Net Income/Loss (FY2025): -kr 171.4M
Total Assets (FY2025): kr 769.3M
Total Equity (FY2025): kr 604.6M
Cash Flows from Operating Activities (FY2025): -kr 193.2M

Source: Xspray Pharma AB (publ) annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.